Creating a new drug from scratch takes many years and billions of dollars. While discovery of new molecules against SARS-CoV-2 and other emerging viruses is imperative, the world also needs solutio…
Dr. Maureen Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inheri…
The effects of COVID-19 have dramatically changed the way we live, learn and work. While many things have come to a standstill, Wistar research has never stopped and even new educational proje…
Despite an unprecedented volume of research, there are still many unanswered questions on COVID-19, especially regarding the extremely varied clinical course the disease takes, ranging from asympto…
When I graduated from medical school, many years ago, I took an oath. An oath to preserve and uphold human life. All human life. What I saw in the horrific, excruciating minutes of the video in Min…
Research assistant professor Ami Patel has spent her career committed to using novel engineering approaches to fight harmful infectious diseases. Her work focuses on developing next generation vacc…
In the middle of the pandemic, Wistar graduate student Kevin Alicea-Torres is living a busy and exciting life, preparing to defend his thesis and graduate with a Ph.D. in cell and molecular biology…
In mere weeks, philanthropic support of Wistar’s Coronavirus Discovery Fund has exceeded $1.6M in new funding thanks to an extraordinary response from individuals, foundations, and corpor…
Dr. Ertl is a global leader in Wistar’s Vaccine & Immunotherapy Center whose research focuses on preventing rabies, HBV, HIV, HPV, influenza, and other deadly viruses using innovative patented …
The Pennsylvania Cancer Alliance, a coalition of the state’s leading cancer research institutions, meets every year in early May for a lobbying initiative to engage legislators and spotlight the im…
